References: Axial spondyloarthritis

  • Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, et al. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N Engl J Med 2015;373(26):2534-48. https://www.ncbi.nlm.nih.gov/pubmed/26699169
  • Chen J, Lin S, Liu C. Sulfasalazine for ankylosing spondylitis. Cochrane Database Syst Rev 2014;(11):CD004800. https://www.ncbi.nlm.nih.gov/pubmed/25427435
  • Chen J, Veras MM, Liu C, Lin J. Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev 2013;(2):CD004524. https://www.ncbi.nlm.nih.gov/pubmed/23450553
  • de Winter JJ, van Mens LJ, van der Heijde D, Landewe R, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther 2016;18(1):196. https://www.ncbi.nlm.nih.gov/pubmed/27586785
  • Kroon FP, van der Burg LR, Ramiro S, Landewe RB, Buchbinder R, Falzon L, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev 2015;2015(7):CD010952. https://www.ncbi.nlm.nih.gov/pubmed/26186173
  • Mandl P, Navarro-Compan V, Terslev L, Aegerter P, van der Heijde D, D'Agostino MA, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 2015;74(7):1327-39. https://www.ncbi.nlm.nih.gov/pubmed/25837448
  • Mattey DL, Dawson SR, Healey EL, Packham JC. Relationship between smoking and patient-reported measures of disease outcome in ankylosing spondylitis. J Rheumatol 2011;38(12):2608-15. https://www.ncbi.nlm.nih.gov/pubmed/21965641
  • Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, et al. TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev 2015;(4):CD005468. https://www.ncbi.nlm.nih.gov/pubmed/25887212
  • Millner JR, Barron JS, Beinke KM, Butterworth RH, Chasle BE, Dutton LJ, et al. Exercise for ankylosing spondylitis: An evidence-based consensus statement. Semin Arthritis Rheum 2016;45(4):411-27. https://www.ncbi.nlm.nih.gov/pubmed/26493464
  • Poddubnyy D, Hermann KG, Callhoff J, Listing J, Sieper J. Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS). Ann Rheum Dis 2014;73(5):817-23. https://www.ncbi.nlm.nih.gov/pubmed/24389297
  • Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Marker-Hermann E, Zeidler H, et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis 2011;70(8):1369-74. https://www.ncbi.nlm.nih.gov/pubmed/21622969
  • Robinson PC, Bird P, Lim I, Saad N, Schachna L, Taylor AL, et al. Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA). Int J Rheum Dis 2014;17(5):548-56. https://www.ncbi.nlm.nih.gov/pubmed/24673897
  • Roche D, Badard M, Boyer L, Lafforgue P, Pham T. Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials. Arthritis Res Ther 2021;23(1):192. https://www.ncbi.nlm.nih.gov/pubmed/34271991
  • Sampaio-Barros PD, Bertolo MB, Kraemer MH, Marques-Neto JF, Samara AM. Undifferentiated spondyloarthropathies: a 2-year follow-up study. Clin Rheumatol 2001;20(3):201-6. https://www.ncbi.nlm.nih.gov/pubmed/11434474
  • Sieper J, Listing J, Poddubnyy D, Song IH, Hermann KG, Callhoff J, et al. Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). Ann Rheum Dis 2016;75(8):1438-43. https://www.ncbi.nlm.nih.gov/pubmed/26242443
  • Steiman AJ, Pope JE, Thiessen-Philbrook H, Li L, Barnabe C, Kalache F, et al. Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials. Rheumatol Int 2013;33(5):1105-20. https://www.ncbi.nlm.nih.gov/pubmed/23292213
  • Wanders A, Heijde D, Landewe R, Behier JM, Calin A, Olivieri I, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005;52(6):1756-65. https://www.ncbi.nlm.nih.gov/pubmed/15934081
  • Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol 2016;68(2):282-98. https://www.ncbi.nlm.nih.gov/pubmed/26401991